Besides, the amount of CTGF mRNA and protein may change in cancerous tissue during tumor development, and it is not known whether this is a growth advantage for cancer cells or rather the reaction from stromal cells in order to inhibit the proliferation and metastasis (Kikuchi et al. 2007). This evidence concerns the gene CCN2 and neoplasm.